Get A Free Quote / Need a Help?
A Fortune 500 pharmaceutical company was experiencing increased complexity associated with releasing clinical batches to global locations.
Global biologic enterprise drug manufacturer determined that human error was a major contributing factor to considerable manufacturing deviations
Seattle-based biotech with two newly commissed plants to be built on the East and West coasts needed supply chain streamlining - read the case study here.
Pharmaceutical Manufacturing Site Seeks 50% Reduction In Cost Per Gram - read the case study here
